AEterna Zentaris swings to Q4 profit of US$936K from year-ago $2M loss

QUEBEC (CP) - Cancer drug developer AEterna Zentaris Inc. (TSX:AEZ) swung to a fourth quarter profit as a big jump in revenues helped reverse a loss last year. The Quebec-based company said Wednesday it earned US$936,000 or two cents a share for the three months ended Dec. 31....More